News
SRDX
29.82
+0.54%
0.16
Weekly Report: what happened at SRDX last week (0630-0704)?
Weekly Report · 1d ago
SurModics Faces Cyber Incident with IT Systems
TipRanks · 6d ago
SURMODICS INC - MAINTAINS OPERATIONS WITHOUT MATERIAL CUSTOMER IMPACT FROM CYBER INCIDENT - SEC FILING
Reuters · 6d ago
Weekly Report: what happened at SRDX last week (0623-0627)?
Weekly Report · 06/30 09:00
Weekly Report: what happened at SRDX last week (0616-0620)?
Weekly Report · 06/23 09:00
Weekly Report: what happened at SRDX last week (0609-0613)?
Weekly Report · 06/16 09:00
Weekly Report: what happened at SRDX last week (0602-0606)?
Weekly Report · 06/09 09:00
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?
NASDAQ · 06/06 15:31
Weekly Report: what happened at SRDX last week (0526-0530)?
Weekly Report · 06/02 09:00
Weekly Report: what happened at SRDX last week (0519-0523)?
Weekly Report · 05/26 09:00
Weekly Report: what happened at SRDX last week (0512-0516)?
Weekly Report · 05/19 09:00
Weekly Report: what happened at SRDX last week (0505-0509)?
Weekly Report · 05/12 09:00
SurModics (SRDX) Gets a Buy from Lake Street
TipRanks · 05/05 12:46
Weekly Report: what happened at SRDX last week (0428-0502)?
Weekly Report · 05/05 09:00
Are Options Traders Betting on a Big Move in Surmodics Stock?
Barchart · 05/02 08:36
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts
NASDAQ · 05/01 16:46
Analysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)
TipRanks · 05/01 12:14
Surmodics Reports Q2 2025 Results Amid Acquisition Challenges
TipRanks · 05/01 04:17
SurModics Down Over 8%, On Track for Largest Percent Decrease Since March 2023 -- Data Talk
Dow Jones · 04/30 14:58
More
Webull provides a variety of real-time SRDX stock news. You can receive the latest news about Surmodics Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRDX
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.